NCT02879656

Brief Summary

The present collaboration study on the treatment of distal radius fractures is aimed to: (i) to compare non-operative treatment to volar plating in the treatment of initially malaligned distal radius fractures in patients aged 65 and older in terms of functional outcome measured with PRWE (ii) to compare non-operative treatment to volar plating in the treatment of distal radius fractures with early instability during follow-up, i.e., loss of reduction at 1 week (range 5 to 10 days) in patients aged 65 and older in terms of functional outcome measured with PRWE (iii)to compare pain, disability, quality of life, grip strength, and the number of complications after non-operative treatment and the initial and delayed operative treatment of distal radius fracture (iv) to assess the effect of pain catastrophizing score (PCS) on the functional outcome of non-operatively and operatively treated distal radius fracture (v) to assess the association between physical activity and the number of wrist movements measured with Axivity accelerometer and functional outcome measured with PROMs of non-operatively and operatively treated distal radius fractures (vi) to assess the effect of initial as well as the final radiological parameters on the functional outcome (vii) to assess the correlation of probability of radiological malalignment estimated by clinical prediction rule (EWC) with functional outcome measured with PRWE and PASS

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
291

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2018

Longer than P75 for not_applicable

Geographic Reach
3 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 26, 2016

Completed
1.5 years until next milestone

Study Start

First participant enrolled

February 23, 2018

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2023

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

5.3 years

First QC Date

August 17, 2016

Last Update Submit

April 26, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change over time in Patient Rated Wrist Evaluation (PRWE)

    PRWE is the primary outcome measure of wrist pain and disability in the study. The PRWE comprises 15 questions to measure wrist pain and disability in daily activities. In PRWE patients rate wrist pain and disability from 0 to 10 and it consists three subscales: Pain, Function and Cosmetics.

    3 months, 1 year, 2 years

Secondary Outcomes (9)

  • Disability of the wrist measured with the Disability of the Arm, Shoulder and Hand (QuickDASH) questionnaire

    3 months, 1 year, 2 years

  • Quality of life measured with the 15-D

    Baseline, 3 months, 1 year, 2 years

  • Pain measured in Visual Analogue Scale (VAS)

    3 months, 1 year, 2 years

  • Grip strength measured with a dynamometer

    3 months, 1 year

  • Pain catastrophizing measured with the pain catastrophizing scale (PCS)

    baseline, 3 months, 1 year, 2 years

  • +4 more secondary outcomes

Study Arms (2)

Cohort 1

OTHER

Early ustable fracture: Phase 1: After closed reduction, if satisfactory reduction is not achieved fulfilling the inclusion criteria, the patient is allocated to Cohort 1. The patient is randomized to either non-operative (=Arm 1) or operative treatment (=Arm 2). Patients allocated to non-operative treatment will undergo a standard treatment protocol. Patients allocated to operative treatment will undergo a surgery with volar locking plate with modified Henry's volar approach.

Procedure: non-operative treatmentProcedure: operative treatment

Cohort 2

OTHER

Early stable fracture: Phase 1: After closed reduction, if satisfactory position is achieved, the patient is allocated to Cohort 2 and conservative treatment is performed as usually. Phase 2: Patients allocated to Cohort 2, will visit orthopedic outpatient clinic in 1 week in the hospital where the treatment was initially started. If reduction is maintained the patient will undergo standard follow-up visits. If reduction is lost to fulfill the inclusion criteria for surgery the patient is asked to participate to phase 2 of this study. After the patient´s enrollment has been confirmed and informed consent is signed, the patient is randomized to either non-operative (=Arm 3N) or operative treatment (=Arm 3O). If allocated to non-operative treatment patient will undergo the same protocol as those in the Arm 1. Patients allocated to operative treatment will undergo surgery with volar locking plate with standard volar approach.

Procedure: non-operative treatmentProcedure: operative treatment

Interventions

conservative treatment with 5 weeks cast immobilization

Cohort 1Cohort 2

surgery with volar locking plate with modified Henry's volar approach

Cohort 1Cohort 2

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • low energy intra or extra-articular dorsally displaced distal radius fracture within 3 cm of the radiocarpal joint, diagnosed with lateral and posterior-anterior radiographs in ER
  • \>10° dorsal tilt and/or over 2 mm step-off and/or over 3 mm shortening in the radiograph

You may not qualify if:

  • Refuse to participate the study
  • Open fracture more than Gustilo 1 gradus
  • Age under 65 years
  • Chauffeure's or Barton´s fracture
  • Smith´s fracture (volar angulation of the fracture)
  • Does not understand written and spoken guidance in local languages
  • Pathological fracture or previous fracture in the same wrist or forearm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Viborg Regional Hospital

Viborg, Denmark

Location

Jyväskylä Central Hospital

Jyväskylä, Finland

Location

Pori Central Hospital

Pori, Finland

Location

Tampere University Hospital

Tampere, 33820, Finland

Location

Karolinska University Hospital

Stockholm, Sweden

Location

Related Publications (2)

  • Hevonkorpi TP, Launonen AP, Reito A, Schandorff Skjaerbaek M, Li Y, Luokkala T, Kukkonen J, Paloneva J, Kvistgaard Ostergaard H, Fellander-Tsai L, Laitinen MK, Sumrein BO, Mechlenburg I, Mattila VM; as the NITEP Group (Nordic Innovative Trial to Evaluate osteoPorotic fractures). Nonoperative treatment versus volar locking plating for distal radius fracture in patients aged 65 years or older (DRIFT trial): A randomized controlled trial. PLoS Med. 2025 Sep 5;22(9):e1004728. doi: 10.1371/journal.pmed.1004728. eCollection 2025 Sep.

  • Hevonkorpi TP, Launonen AP, Raittio L, Luokkala T, Kukkonen J, Reito A, Sumrein BO, Laitinen MK, Mattila VM; NITEP-group. Nordic Innovative Trial to Evaluate OsteoPorotic Fractures (NITEP-group): non-operative treatment versus surgery with volar locking plate in the treatment of distal radius fracture in patients aged 65 and over - a study protocol for a prospective, randomized controlled trial. BMC Musculoskelet Disord. 2018 Apr 5;19(1):106. doi: 10.1186/s12891-018-2019-5.

MeSH Terms

Conditions

Wrist Fractures

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Study Officials

  • Ville Mattila, Prof

    Tampere University Hospital

    STUDY DIRECTOR
  • Antti Launonen, MD

    Tampere University Hospital

    PRINCIPAL INVESTIGATOR
  • Minna Laitinen, adjunct prof

    Tampere University Hospital

    STUDY CHAIR
  • Teemu Hevonkorpi, MD

    Tampere University Hospital

    STUDY CHAIR
  • Lauri Raittio, MD

    Tampere University Hospital

    STUDY CHAIR
  • Toni Luokkala, MD

    Central Finland Central Hospital

    STUDY CHAIR
  • Aleksi Reito, MD

    Central Finland Central Hospital

    STUDY CHAIR
  • Juha Kukkonen, MD

    Satakunta Central Hospital

    STUDY CHAIR
  • Li Felländer-Tsai, MD

    Karolinska University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

August 17, 2016

First Posted

August 26, 2016

Study Start

February 23, 2018

Primary Completion

June 6, 2023

Study Completion

June 6, 2023

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations